Encapsulating human stem-cell-derived beta cells in microcapsules made with an immune-cell-repelling protein restored glucose metabolism in diabetic mice and protected the cells from immune system ...

Homogeneous molecular catalysts are highly active and selective as they possess well-tailored structures and accessible sites. Unfortunately, the difficulty related to catalyst recovery impedes their ...

Encapsulating human stem-cell-derived beta cells in microcapsules made with a protein that repels key immune cells restored glucose metabolism in diabetic mice and protected the cells from immune ...

On March 26, 1954, National Cash Register sold its first roll of carbonless paper. Developed in collaboration with Appleton Coated Paper, the product harnessed brand-new microencapsulation technology ...

PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, said, “We have completed another study that proves exactly what we expected to find in the data. Like previous biocompatibility studies on ...

The need to avoid immunosuppression is often the driving force behind research into alternative therapeutic options for the treatment of a range of diseases. One such disease is type I diabetes, which ...